(Date:12/1/2008)...irl with Hypophosphatasia Treated With ENB-0040 at...nnipeg , , MONTREAL, Dec. 1 ...ny focused on developing novel therapeutics for se...st infant patient in its clinical program for hypo...zyme Replacement Therapy (ERT) with ENB-0040 for t...
(Date:12/1/2008)...ISTGARD, Denmark, December 1 /PRNewswire-FirstCall...007 with the intent to procure an MVA-based,thir...vernment Services,Canada, on behalf of the Canadi...contract to Bavarian Nordic for the delivery of IM...d to use IMVAMUNE(R) as part of the,country,s bio...
(Date:11/30/2008)... , CHICAGO, Dec. 1 O...cerebral blood flow and a greater number of small ...presented today at the annual meeting of the Radio... The study, conducted at the University of Nort... compare brain scans of older adults who exercise ...
(Date:11/27/2008)...udy finds the majority of acute lymphoblastic leuk...nt at the time of diagnosis , , MEMPHIS, Te... at St. Jude Children,s Research Hospital have ide...cells of children with acute lymphoblastic leukemi...athway to designing treatments for ALL relapse in ...
Breaking Medicine Technology:Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 2Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 5The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 2The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 3Exercise Helps Prevent Age-Related Brain Changes in Older Adults 2Exercise Helps Prevent Age-Related Brain Changes in Older Adults 3St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 3AMDL Inc Closes Private Placement of Convertible Notes 7718 1AMDL Inc Closes Private Placement of Convertible Notes 7718 2AMDL Inc Closes Private Placement of Convertible Notes 7718 3AMDL Inc Closes Private Placement of Convertible Notes 7718 4Simulations help explain fast water transport in nanotubes 4912 1Simulations help explain fast water transport in nanotubes 4912 2Canadian Company Sued for Defrauding Thousands of U S Consumers of Dietary Supplements 26497 1Canadian Company Sued for Defrauding Thousands of U S Consumers of Dietary Supplements 26497 2Joint Commission Urges Patients to Speak Up About Pain 3071 1Joint Commission Urges Patients to Speak Up About Pain 3071 2Joint Commission Urges Patients to Speak Up About Pain 3071 3...ALTHAM, Mass.--(BUSINESS WIRE)--Apr 17, 2007 - Adn...esentation of the abstract,"CT-322: A specific VEG...ity in preclinical tumor models comparable to pan-...inib and sorafenib" at the,American Association fo...s Angeles, CA. The lead author is Irvith Carvajal,...
...SUNNYVALE, Calif. and LOS ANGELES, April 18, 2007,...y announced data,from two preclinical studies, one...histone deacetylase (HDAC) inhibitor and,another d...its,Bruton,s tyrosine kinase (BTK) inhibitor compo...ciation for Cancer Research (AACR),2007 Annual Mee...
Other Medicine Technology:Adnexus Therapeutics Announces Presentation at the American,Association for Cancer Research (AACR) on Clinical Product,Candidate, CT-322 2Adnexus Therapeutics Announces Presentation at the American,Association for Cancer Research (AACR) on Clinical Product,Candidate, CT-322 3Adnexus Therapeutics Announces Presentation at the American,Association for Cancer Research (AACR) on Clinical Product,Candidate, CT-322 4Pharmacyclics Identifies Functional Biomarkers for its Novel HDAC,Inhibitor and Demonstrates Preclinical Anti-Tumor Activity with,Bruton's Tyrosine Kinase Inhibitors 2Pharmacyclics Identifies Functional Biomarkers for its Novel HDAC,Inhibitor and Demonstrates Preclinical Anti-Tumor Activity with,Bruton's Tyrosine Kinase Inhibitors 3Pharmacyclics Identifies Functional Biomarkers for its Novel HDAC,Inhibitor and Demonstrates Preclinical Anti-Tumor Activity with,Bruton's Tyrosine Kinase Inhibitors 4Pharmacyclics Identifies Functional Biomarkers for its Novel HDAC,Inhibitor and Demonstrates Preclinical Anti-Tumor Activity with,Bruton's Tyrosine Kinase Inhibitors 5(Date:12/1/2008)...rstCall/ -- Senetek PLC,(OTC Bulletin Board: SNKT...pment of technologies that target the science of h... AG, specialists in the fields of strategic,devel... offices in Zurich,Bern and Geneva has published...search Report, available in the "Investors" sectio...
(Date:12/1/2008)...against plantar fasciitis, researchers say , ...n researchers say they,ve developed a fast, effect...ondition known as plantar fasciitis. , Using a ...ns guided by ultrasound, the researchers say their...ckling a condition that afflicts about one million...
(Date:12/1/2008)...ohnson Public Service Announcement (PSA) focuses o... PARK, Ill., Dec. 1 T...he Magic Johnson Foundation and Abbott are cal...mily and friends about HIV/AIDS and its impact on ...rking tool allows Facebook users to stand with Mag...
(Date:12/1/2008)...e Cross Blue Shield of Michigan,provided more tha...nformation,today to Michigan Attorney General Mik...on about Michigan,s individual health insurance ma...n,s individual health insurance market,and escala...,s last-resort,insurance carrier, in its individu...
Breaking Medicine News(10 mins):Health News:New Twist on Treatment of Foot Pain 2Health News:New Twist on Treatment of Foot Pain 3Health News:Video: Magic Johnson Foundation and Abbott Call for Greater Prevention, Testing and Treatment on World AIDS Day 2Health News:Video: Magic Johnson Foundation and Abbott Call for Greater Prevention, Testing and Treatment on World AIDS Day 3Health News:Video: Magic Johnson Foundation and Abbott Call for Greater Prevention, Testing and Treatment on World AIDS Day 4Health News:Video: Magic Johnson Foundation and Abbott Call for Greater Prevention, Testing and Treatment on World AIDS Day 5Health News:Blue Cross Blue Shield of Michigan Answers Attorney General 2Health News:Blue Cross Blue Shield of Michigan Answers Attorney General 3... by addiction specialists and published in Lancet ...trimental to health than class A drugs. Prof David.... This study rates alcohol as the fifth most da...d and safety. Tobacco is considered more addictiv...
...disease tuberculosis is on the march. Figures rele...an increase by 2 percent in number of TB cases ove...orld TB Day, which falls on the 24th of March, a...ngland, Wales and Northern Ireland. London contin...
...ening Committee of UK are considering ways to regu...According to Sir Muir Gray, program director of th...ence of these screening programs creating unwant...tant pressure being put on the National Health Ser...
.... Steriani Elavsky, women passing through their me...ife// when they exercised. The improvements in hea...tive effect on their perceived quality of life. T...tive menopausal women who were divided into three ...
Other Medicine News:Health News:TB Cases on the Rise 2Inquire
Inquire
Hydragel K20 is Sebia's quality line of manual agarose gel electrophoresis products. Samples are applied utilizing the same patented applicator combs that is used for sample application on the HYDRAS
...ew device for skin extension.Thanks to its titaniu...ws a constant and powerful creep reaction of the t... effectiveness makes the FRECHET EXTENDER® a s...ys. Furthermore it is invisible when implanted. Ma...
Medicine Products: